Clear cell renal cell carcinoma (ccRCC) is known to occur across the adult lifetime traversing the spectrum of age-related organismal changes. Little is known as to how the aging process may affect the course of renal cell carcinoma (RCC) and the repertoire of genes involved.
Using The Cancer Genome Atlas (n = 436) and Cancer Genomics of the Kidney (n = 89) datasets, we applied regression analysis to examine associations between patient age and gene expression profiles in ccRCC tumors and normal kidney tissues. Pathway enrichment analysis was performed to identify cellular process that is affected by aging in ccRCC. Moreover, connectivity mapping analysis was used to predict age-dependent response to drug treatments.
Our analysis revealed different age-dependent gene expression spectra in ccRCC and normal kidney tissues. These findings were significant and independently reproducible in both datasets examined. Age up-regulated genes, showing higher expression in older patients, were significantly enriched (false discovery rate <0.05) in normal tissues for pathways associated with immune response and extracellular matrix organization, whereas age up-regulated genes in tumors were enriched for metabolism and oxidation pathways. Strikingly, age down-regulated genes in normal cells were also enriched for metabolism and oxidation, while those in tumors were enriched for extracellular matrix organization. Further in silico analysis of potential drug targets predicted preferential efficacy of Phosphoinositide 3-kinase inhibitor or immunotherapy in association with age.
We report on previously unrecognized associations between age and molecular underpinnings of RCC, including age-associated expression of genes implicated in RCC development or treatment.
Urologic oncology. 2018 Nov 23 [Epub ahead of print]
Lara Feulner, Hamed S Najafabadi, Simon Tanguay, Janusz Rak, Yasser Riazalhosseini
Department of Human Genetics, McGill University, McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada., Department of Surgery, Division of Urology, McGill University Health Center, McGill University, Montreal, Quebec, Canada., Department of Pediatrics, Division of Experimental Medicine, Faculty of Medicine, McGill University and the Research Institute of the McGill University Health Centre, Montreal Children's Hospital, Montreal, Quebec, Canada. Electronic address: ., Department of Human Genetics, McGill University, McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada. Electronic address: .